<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02755701</url>
  </required_header>
  <id_info>
    <org_study_id>LIV_ACT Trial_I</org_study_id>
    <nct_id>NCT02755701</nct_id>
  </id_info>
  <brief_title>The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascites</brief_title>
  <official_title>The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascites: A Multi-center, Randomized, Double-blind, Placebo-controlled, Investigator Initiated Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Soonchunhyang University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kyunghee University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wonju Severance Christian Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Korea University Anam Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hanyang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Soonchunhyang University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the efficacy of branched-chain amino acid in serum albumin level in cirrhotic
      patients with ascites.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Branched-chain amino acid (BCAA) is known to reduce the relapse rate of liver cancer as it is
      associated with insulin resistance and has been reported to improve the progression of liver
      fibrosis when used in combination with an angiotensin-converting enzyme. With regard to the
      effect of liver function improvement, in a research conducted in South Korea, approximately
      41.2% of the patients showed recovery of the normal albumin level when BCAA was administered
      to them for about 10 weeks during radiation therapy for liver cancer. Additionally, in other
      overseas researches, the changes in the values of total protein and albumin were
      significantly smaller in the patients who underwent transarterial chemoembolization (TACE) to
      whom BCAA was administered than in those to whom BCAA was not administered.

      The hypothesis of this study is that the serum albumin value will be increased significantly
      in the cirrhotic patients with ascites to whom BCAA is administered than the patients to whom
      placebo is administered.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in serum albumin level</measure>
    <time_frame>24 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in serum albumin level</measure>
    <time_frame>12 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rates of albumin normalization</measure>
    <time_frame>12, 24 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dose of diuretics</measure>
    <time_frame>12, 24 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in terms of severity of ascites (International Ascites Club grade)</measure>
    <time_frame>24 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Development rate of cirrhotic complications(including acute kidney injury, hepatic encephalopathy, variceal bleeding, peritonitis, etc)</measure>
    <time_frame>24 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in Child-Pugh score, class</measure>
    <time_frame>24 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in MELD, MELD-Na</measure>
    <time_frame>24 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in sarcopenia</measure>
    <time_frame>24 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in muscle mass</measure>
    <time_frame>24 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in muscle strength</measure>
    <time_frame>24 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in SF-36(short form-36)</measure>
    <time_frame>24 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in HOMA-IR(homeostatic model assessment-insulin resistance)</measure>
    <time_frame>24 week</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in serum cystatin c</measure>
    <time_frame>12, 24 week</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in HVPG(hepatic venous pressure gradient)</measure>
    <time_frame>24 week</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Radiological characteristics of patients who have reaction to the branched-chain amino acid agent</measure>
    <time_frame>24 week</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in serum creatinine</measure>
    <time_frame>12, 24 week</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Improvement on PHES (psychometric hepatic encephalopathy score)</measure>
    <time_frame>24 week</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Improvement on relative adrenal insufficiency</measure>
    <time_frame>24 week</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">188</enrollment>
  <condition>Cirrhosis</condition>
  <condition>Ascites</condition>
  <arm_group>
    <arm_group_label>BCAA group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Branched-chain amino acid, 4.15g, Tid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo, 4.15g, Tid</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Branched-chain Amino Acid</intervention_name>
    <description>BCAA (livact) will be administered 3 times a day during 24 weeks</description>
    <arm_group_label>BCAA group</arm_group_label>
    <other_name>Livact®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo will be administered in the same way</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 19 and ≤ 70 years;

          -  Presence of liver cirrhosis

          -  Serum albumin level ≤ 3.5g/dl, ultrasound or CT scan confirmed ascites (≥Grade 1)

          -  No administration of diuretics and BCAA within the past 1 week

          -  Voluntary consent to take part in this trial

        Exclusion Criteria:

          -  Child-Pugh score &gt; 12

          -  Having been diagnosed as HCC within the past 5 years

          -  Serum creatinine &gt; 1.5mg/dl

          -  Serum bilirubin &gt; 5.0mg/dl

          -  Presence of such complications as SBP, or hepatic encephalopathy(West Haven grade ≥ 3)

          -  Patients who experienced organ failure by acute exacerbation of liver cirrhosis within
             the past 1 month

          -  Presence of serious cardiac or respiratory disease

          -  Contraindicated to either diuretics or BCAA

          -  Having commenced anti-viral treatment against hepatitis C, B within the past 1 month

          -  Pregnant or lactating women

          -  Chronic alcohol taker

          -  Woman patients who do not agree to the contraception from baseline to 12 month

          -  Unsuitable patients judged by investigator

          -  Patients participating in another clinical trial within 1 month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sang Gyune Kim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Soon Chun Hyang University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sang Gyune Kim</last_name>
    <phone>82-32-621-5079</phone>
    <email>mcnulty@schmc.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>W.Ray Kim, Professor</last_name>
      <phone>650-725-6511</phone>
      <email>wrkim@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>W.Ray Kim, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wonju severance christian hospital</name>
      <address>
        <city>Wonju</city>
        <state>Gangwon</state>
        <zip>26426</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moon Young Kim, Professor</last_name>
    </contact>
    <investigator>
      <last_name>Moon Young Kim</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soon Chun Hyang University Bucheon Hospital</name>
      <address>
        <city>Bucheon</city>
        <state>Gyeonggi do</state>
        <zip>14584</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang Gyune Kim, Professor</last_name>
      <phone>82-32-621-5079</phone>
      <email>mcnulty@schmc.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Sang Gyune Kim</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kyunghee university hospital</name>
      <address>
        <city>Seoul</city>
        <zip>02477</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae Jun Shim, Professor</last_name>
    </contact>
    <investigator>
      <last_name>Jae Jun Shim</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Korea university anam hospital</name>
      <address>
        <city>Seoul</city>
        <zip>02841</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yeon Seok Seo, Professor</last_name>
    </contact>
    <investigator>
      <last_name>Yeon Seok Seo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Severance hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun Yong Park, Professor</last_name>
    </contact>
    <investigator>
      <last_name>Jun Yong Park</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soonchunhyang university seoul hospital</name>
      <address>
        <city>Seoul</city>
        <zip>04401</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soung Won Jeong, Professor</last_name>
    </contact>
    <investigator>
      <last_name>Soung Won Jeong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hanyang university hospital</name>
      <address>
        <city>Seoul</city>
        <zip>04763</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dae Won Jun, Professor</last_name>
    </contact>
    <investigator>
      <last_name>Dae Won Jun</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2016</study_first_submitted>
  <study_first_submitted_qc>April 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2016</study_first_posted>
  <last_update_submitted>August 31, 2016</last_update_submitted>
  <last_update_submitted_qc>August 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Soonchunhyang University Hospital</investigator_affiliation>
    <investigator_full_name>Sang Gyune Kim</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ascites</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

